APA (7th ed.) Citation

Slobbe, P., & Stehle, G. (2014). Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors. Nuclear medicine and biology, 41(9), . https://doi.org/10.1016/j.nucmedbio.2014.06.005

Chicago Style (17th ed.) Citation

Slobbe, Paul, and Gerd Stehle. "Development of [18F]afatinib as New TKI-PET Tracer for EGFR Positive Tumors." Nuclear Medicine and Biology 41, no. 9 (2014). https://doi.org/10.1016/j.nucmedbio.2014.06.005.

MLA (9th ed.) Citation

Slobbe, Paul, and Gerd Stehle. "Development of [18F]afatinib as New TKI-PET Tracer for EGFR Positive Tumors." Nuclear Medicine and Biology, vol. 41, no. 9, 2014, https://doi.org/10.1016/j.nucmedbio.2014.06.005.